Skip to main content
Clinical Trials/NCT04301258
NCT04301258TerminatedNot Applicable

ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry

AlloSource5 sites in 1 country48 target enrollmentStarted: January 6, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
AlloSource
Enrollment
48
Locations
5
Primary Endpoint
Long-Term Outcomes of ProChondrix CR

Study Overview

Brief Summary

The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.

Detailed Description

This multi-center, observational registry will be used to evaluate the effectiveness of ProChondrix CR in patients who undergo treatment for an articular cartilage defect in the knee, ankle, foot or hip.

This registry will be performed at up to 30 clinical sites across the United States.

Patient follow-up will occur following an articular cartilage repair procedure in which the patient receives ProChondrix CR. During this follow-up period, each patient will be evaluated at least four (4) times at: 3, 6, 12 and 24 months after surgical intervention and will continue annually for as long as patients are willing to fill out questionnaires and outcomes assessments up to 10 years post operatively.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Diagnosed by physician to have a cartilage defect in the knee, ankle, foot or hip that requires surgical intervention;
  • Will be having, or has had, a cartilage repair procedure using ProChondrix CR;
  • Has the ability to understand the requirements of the registry, to provide written informed consent and to comply with the registry protocol;

Exclusion Criteria

  • Is a ward of the state, prisoner, or transient.

Outcomes

Primary Outcomes

Long-Term Outcomes of ProChondrix CR

Time Frame: 10 Years Post-Operative

Obtain long-term results on patients who have undergone an articular cartilage repair procedure using ProChondrix CR, as assessed by patient reported outcomes.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
AlloSource
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials